Inicio › Melanoma › Ohio › Cleveland
Ensayos clínicos de Melanoma en Cleveland, OH
14 estudios para Melanoma buscan participantes en centros de Cleveland y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
ReclutandoFase 3
- Seidman Cancer Center, Cleveland
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
ReclutandoFase 1/2
- University Hospitals Cleveland Medical Center, Cleveland
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
ReclutandoFase 1/2
- Cleveland Clinic Taussig Cancer Center, Cleveland
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
ReclutandoFase 3
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · A 10 mi de distancia
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
ReclutandoFase 2
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · A 10 mi de distancia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
ReclutandoEstudio observacional
- Cleveland Clinic, Cleveland
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
ReclutandoFase 1
- Cleveland Clinic, Cleveland
Project: Every Child for Younger Patients With Cancer
ReclutandoEstudio observacional
- Rainbow Babies and Childrens Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
Neoadjuvant Darovasertib in Primary Uveal Melanoma
ReclutandoFase 3
- Cole Eye Institute-9500 Euclid Ave, Cleveland
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
ReclutandoFase 1/2
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Mayfield Heights · A 12 mi de distancia
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Cleveland Clinic, Cleveland
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Reclutando
- University Hospitals Cleveland Medical Centre, Cleveland
- University Hospitals Chagrin Highlands Medical Centre, Orange · A 12 mi de distancia
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
ReclutandoFase 1/2
- Cleveland Clinic, Cleveland
Más información sobre Melanoma en MedlinePlus
Ensayos de Melanoma en otras ciudades
- Houston, TX61 estudios
- New York City, NY41 estudios
- Nashville, TN34 estudios
- Los Angeles, CA34 estudios
- Pittsburgh, PA31 estudios
- Boston, MA25 estudios
- St. Louis, MO23 estudios
- Durham, NC22 estudios
- Philadelphia, PA22 estudios
- Tampa, FL21 estudios
- Columbus, OH21 estudios
- Dallas, TX21 estudios
Otros estudios en Cleveland
- Cáncer de pulmón de células no pequeñas48 estudios
- Cáncer (todos los tipos)36 estudios
- Cáncer de seno33 estudios
- Fallo cardíaco31 estudios
- Cáncer metastásico30 estudios
- Cáncer de próstata30 estudios
- Cáncer de ovario29 estudios
- Cáncer de pulmón26 estudios
- Cáncer del colon y del recto25 estudios
- Leucemia mielógena aguda20 estudios
- Carcinoma de células escamosas de cabeza y cuello20 estudios
- Enfermedad cardiovascular20 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.